Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
572816
Created by
admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023
|
||
|
FDA ORPHAN DRUG |
572716
Created by
admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1879918-31-6
Created by
admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023
|
PRIMARY | |||
|
C125549
Created by
admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023
|
PRIMARY | |||
|
FG-29
Created by
admin on Sat Dec 16 13:40:40 GMT 2023 , Edited by admin on Sat Dec 16 13:40:40 GMT 2023
|
PRIMARY | |||
|
7K5O7P6QIU
Created by
admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023
|
PRIMARY | |||
|
7K5O7P6QIU
Created by
admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023
|
PRIMARY | |||
|
Loncastuximab tesirine
Created by
admin on Sat Dec 16 13:40:40 GMT 2023 , Edited by admin on Sat Dec 16 13:40:40 GMT 2023
|
PRIMARY | |||
|
2540964
Created by
admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023
|
PRIMARY | |||
|
10586
Created by
admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023
|
PRIMARY |
ACTIVE MOIETY